Hancock Whitney Corp Concert Pharmaceuticals, Inc. Transaction History

Hancock Whitney Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$8.67 - $10.82 $107,889 - $134,644	-12,444 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$7.8 - $11.52 $97,063 - $143,354	12,444 New	12,444 $124,000
Q1 2019 May 13, 2019	SELL	$12.07 - $17.54 $371,405 - $539,723	-30,771 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$11.25 - $16.17 $86,276 - $124,007	-7,669 Reduced 19.95%	30,771 $386,000
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $50,895 - $70,983	-3,970 Reduced 9.36%	38,440 $570,000
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $713,760 - $918,600	42,410 New	42,410 $714,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.